Ram Waisbourd - Nov 16, 2021 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Chief Operating Officer and Chief Business Officer
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Ram Waisbourd
Stock symbol
ETNB
Transactions as of
Nov 16, 2021
Transactions value $
-$101,920
Form type
4
Date filed
11/18/2021, 05:37 PM
Previous filing
Oct 20, 2021
Next filing
Dec 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Options Exercise $13.5K +7K $1.93* 7K Nov 16, 2021 Direct
transaction ETNB Common Stock Sale -$115K -7K -100% $16.49 0 Nov 16, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Options Exercise $0 -7K -27.77% $0.00 18.2K Nov 16, 2021 Common Stock 7K $1.93 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $16.08 to $17.26. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This option represents a right to purchase a total of 102,203 shares of the Issuer's common stock, one quarter of which vested on May 1, 2019, with the remaining three quarters vesting in equal quarterly installments over the following three years.

Remarks:

Chief Operating Officer and Chief Business Officer